Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001005477-99-001271
Filing Date
1999-03-19
Accepted
1999-03-19 00:00:00
Documents
10
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT 10-K405 289092
2 CERTIFICATE OF DESIGNATION EX-3.6 19788
3 EMPLOYMENT AGREEMENT EX-10.60 22041
4 PURCHASE AGREEMENT EX-10.61 61646
5 EMPLOYMENT AGREEMENT EX-10.63 40440
6 THIRD AMENDMENT TO SUBLEASE EX-10.64 11542
7 COMPUTATION OF NET LOSS PER COMMON SHARE EX-11.1 1429
8 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23.1 602
9 POWER OF ATTORNEY EX-24.1 149
10 FINANCIAL DATA SCHEDULE EX-27.1 2507
  Complete submission text file 0001005477-99-001271.txt   451643
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21589 | Film No.: 99568922
SIC: 2834 Pharmaceutical Preparations